| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 72.57B | 75.99B | 69.88B | 59.32B | 53.74B | 48.70B |
| Gross Profit | 33.03B | 34.69B | 33.70B | 28.81B | 26.66B | 22.55B |
| EBITDA | 18.05B | 20.85B | 17.43B | 15.01B | 13.47B | 10.33B |
| Net Income | 10.03B | 11.71B | 10.32B | 9.22B | 9.24B | 6.37B |
Balance Sheet | ||||||
| Total Assets | 93.21B | 97.49B | 93.27B | 66.72B | 58.53B | 54.48B |
| Cash, Cash Equivalents and Short-Term Investments | 34.75B | 32.80B | 32.37B | 28.21B | 27.65B | 22.43B |
| Total Debt | 16.43B | 15.00B | 18.03B | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 34.30B | 34.73B | 37.78B | 15.33B | 13.70B | 12.68B |
| Stockholders Equity | 58.91B | 62.76B | 55.49B | 51.39B | 44.83B | 41.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.02B | 10.29B | 7.40B | 10.10B | 9.34B |
| Operating Cash Flow | 0.00 | 8.66B | 10.68B | 7.57B | 10.17B | 9.61B |
| Investing Cash Flow | 0.00 | -1.39B | -20.41B | -3.03B | -1.01B | -1.69B |
| Financing Cash Flow | 0.00 | -6.88B | 13.81B | -3.90B | -3.02B | -2.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥152.57B | 14.81 | ― | 2.30% | 13.82% | 37.07% | |
75 Outperform | ¥150.08B | 9.34 | 11.52% | 2.76% | 4.00% | 38.72% | |
74 Outperform | ¥281.85B | 28.54 | ― | 0.22% | 25.00% | 62.07% | |
67 Neutral | ¥144.74B | 15.01 | ― | 2.22% | 9.29% | 1.18% | |
66 Neutral | ¥169.44B | 15.99 | 18.89% | 2.78% | 11.90% | 60.66% | |
65 Neutral | ¥31.54B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |